Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?

Am J Hematol. 2020 Aug;95(8):E210-E213. doi: 10.1002/ajh.25870. Epub 2020 Jul 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus*
  • Bone Marrow
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / physiopathology*
  • Female
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Neutropenia / drug therapy
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / physiopathology*
  • SARS-CoV-2

Substances

  • Granulocyte Colony-Stimulating Factor
  • Hydroxychloroquine

Supplementary concepts

  • COVID-19 drug treatment